Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00846014

Asthma Exacerbation and Helium-3 MRI

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Massachusetts, Worcester · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this research is to use Helium-3 MRI to see the changes in airflow of the lungs at different times of an attack. These three stages are immediately after the attack, 1 month later and 4-6 months later.

Detailed description

Asthma is a pulmonary disorder that affects millions of people each year. The exact method of exacerbation is still under some discussion. Currently there is no cure for the disorder but treatment is of a wide variety. This study is meant to image the asthmatic lung at various time points post exacerbation. Since pulmonary imaging is currently limited to radiation techniques, this method will allow exacerbated images without the unnecessary exposure to radiation.

Conditions

Interventions

TypeNameDescription
DRUGHelium-3Patients will be required to breath in individual 1 liter bags of gas while in an MRI to produce lung images. These bags of gas are each made up of 333mL of Helium-3 gas and 667mL of Nitrogen. The first three bags will be administered with a break between each of five to ten minutes. Then the drug aformoterol will be administered and an hour will pass. Then three additional bags will be administered, again with five to ten minutes between each bag.

Timeline

Start date
2009-01-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2009-02-18
Last updated
2012-09-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00846014. Inclusion in this directory is not an endorsement.